Coronavirus Convocatoria FLASH de H2020 para proyectos - Oficina de Proyectos Europeos
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
Convocatoria FLASH de H2020 para proyectos Coronavirus Webinar, 03 de febrero de 2020 Topic SC1-PHE-CORONAVIRUS-2020: Advancing knowledge for the clinical and public health response to the 2019-nCoV epidemic Juan E. Riese PhD MBA Punto Nacional de Contacto – Reto Social 1 H2020 & IMI2 Experto Nacional en el Comité de Programa Reto Social 1 Oficina de Proyectos Europeos – SGPIIRI ISCIII
Descripción del topic Condiciones de participación
Call Identifier: SC1-PHE-CORONAVIRUS-2020 Name: Advancing knowledge for the clinical and public health response to the 2019-nCoV epidemic Scope: Contribution to an efficient patient management and/or public health preparedness and response. Proposals must be timely, with rapid Total Budget: 10 M€ activation, to enable early and valuable outcomes to be established. For increased impact proposals may wish Contribution per project: 2– 3 M€ to build on promising avenues from previous or ongoing research. Opening date: 30 January 2020 Proposals covering investigation of therapeutic and/or vaccines should consider engaging with the European Medical Agency (EMA) to ensure Deadline: 12 February 2020 adequacy of the proposals from a regulatory point of view Type of Action: Research and Innovation (RIA)
Call Identifier: SC1-PHE-CORONAVIRUS-2020 Name: Advancing knowledge for the clinical and public health response to the 2019-nCoV epidemic Scope: The scope of this expression of interest remains broad and may include topics such as: Development of therapeutics, including monoclonal antibodies. As relevant, evidence of regulatory and ethics approvals for the investigational products included in Total Budget: 10 M€ the study(ies) must be presented. Development of point of care diagnostics, ensuring rapid evaluation of candidates based on existing technologies, to allow for Contribution per project: 2– 3 M€ fast case detection and surveillance. Clinical and epidemiological studies, to provide data on epidemiological Opening date: 30 January 2020 characteristics such as viral genotype and pathogenicity; clinical information on host susceptibility and host immune responses; risk factors for severe disease; routes of Deadline: 12 February 2020 transmission and their relative importance; identification of the animal reservoir; etc. Social sciences research, to provide urgently Type of Action: Research and Innovation (RIA) needed answers to social dynamics of the outbreak and the related public health response.
Call Identifier: SC1-PHE-CORONAVIRUS-2020 Name: Advancing knowledge for the clinical and public health response to the 2019-nCoV epidemic Scope: Where relevant, proposals should consider the close collaboration with leading European supercomputing centres to use high-end computing, data and simulation resources in order to accelerate the processes of diagnosis Total Budget: 10 M€ and vaccine research and development. In this respect, the Supercomputing facilities in Barcelona (BSC) and Bologna Contribution per project: 2– 3 M€ (Cineca) are open to collaborate with any successful proposal. Other leading European supercomputer Opening date: 30 January 2020 centres, such as the organisations hosting the PRACE Tier-0 supercomputers, may also be interested Deadline: 12 February 2020 in such collaborations Type of Action: Research and Innovation (RIA)
Call Identifier: SC1-PHE-CORONAVIRUS-2020 Name: Advancing knowledge for the clinical and public health response to the 2019-nCoV epidemic Scope: Proposals funded under this expression of interest will be required to make available their research data, in accordance with the relevant option of Article 29.3 of the H2020 model grant Total Budget: 10 M€ agreement. The use of harmonised protocols in collaboration with other actors is recommended for this purpose. Contribution per project: 2– 3 M€ Expected Impact: Contribution to the diagnosis and clinical Opening date: 30 January 2020 management of patients infected by 2019-nCoV. To contribute to the public health Deadline: 12 February 2020 preparedness and response in the context of the ongoing epidemic of 2019-nCoV. Type of Action: Research and Innovation (RIA)
Descripción del topic Condiciones de participación
Condiciones de participación Consorcio formado como mínimo por 3 entidades independientes entre sí de 3 países de la UE o Estados Asociados. Los umbrales de la evalución para los 3 criterios son: 3 (Excelencia), 4 (Impacto) y 3 (Implementación). El umbral acumulado es 11. Duración del proyecto: sin fijar, pero resultados lo antes posible. Son válidos y necesarios los aspectos SSH, género, éticos, GDPR, IPR, open innovation. Tamaño del consorcio: nº de socios adecuado para alcanzar los objetivos propuestos mediante las actividades indicadas. Presupuesto equilibrado: losrecursos necesarios para que el proyecto alcence sus objetivos ¿Socios UK?: Sí, pero con cautela. Los beneficiarios deberán dar total accesibilidad a los datos obtenidos (art. 29.3 del GA)
Juan E. Riese jriese@eu-isciii.es +34 91 822 21 81 Información esta convocatoria en: https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/opportunities/topic- details/sc1-phe-coronavirus- 2020;freeTextSearchKeyword=;typeCodes=1;statusCodes=31094502;programCode=H2020;prog ramDivisionCode=31047894;focusAreaCode=null;crossCuttingPriorityCode=null;callCode=Defau lt;sortQuery=deadline;orderBy=asc;onlyTenders=false;topicListKey=topicSearchTablePageState
You can also read